NIAID Awards $3.7M Task Order to Leidos Biomedical for COVID-19 R&D Efforts
Contract Overview
Contract Amount: $291,244,978 ($291.2M)
Contractor: Leidos Biomedical Research Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2020-08-31
End Date: 2024-08-30
Contract Duration: 1,460 days
Daily Burn Rate: $199.5K/day
Competition Type: FULL AND OPEN COMPETITION
Pricing Type: COST PLUS FIXED FEE
Sector: R&D
Official Description: NIAID DCR OPERATIONAL TASK ORDER COVID FUNDING IN THE AMOUNT OF $3,706,224 FOR COVID RELATED EFFORTS ON THIS TASK ORDER
Place of Performance
Location: FREDERICK, FREDERICK County, MARYLAND, 21702
State: Maryland Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $291.2 million to LEIDOS BIOMEDICAL RESEARCH INC for work described as: NIAID DCR OPERATIONAL TASK ORDER COVID FUNDING IN THE AMOUNT OF $3,706,224 FOR COVID RELATED EFFORTS ON THIS TASK ORDER Key points: 1. Spending focuses on COVID-19 related research and development, a critical area. 2. Leidos Biomedical Research Inc. is a significant player in health and biomedical services. 3. The contract is a delivery order under a larger contract, indicating potential for follow-on work. 4. The R&D sector is characterized by innovation but also inherent project risks.
Value Assessment
Rating: fair
The $3.7M task order is for specific COVID-19 efforts. Benchmarking against similar R&D task orders is difficult without more detailed scope information, but the amount appears reasonable for specialized research support.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, suggesting a competitive bidding process. This method generally promotes price discovery and potentially better value for the government.
Taxpayer Impact: The funding supports critical COVID-19 research, aiming for advancements that could benefit public health, justifying the taxpayer investment.
Public Impact
Supports ongoing research into COVID-19, contributing to national health security. Funds critical operational tasks for the National Institutes of Health (NIH). The award to Leidos Biomedical Research Inc. highlights their role in government health initiatives. Potential for advancements in understanding and combating the virus.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Lack of detailed scope for the $3.7M task order.
- Potential for cost overruns in R&D projects.
- Reliance on a single delivery order under a larger contract.
Positive Signals
- Awarded under full and open competition.
- Supports critical COVID-19 research.
- Experienced contractor in Leidos Biomedical Research Inc.
Sector Analysis
This award falls within the Research and Development sector, specifically for physical, engineering, and life sciences. Spending in this area is crucial for innovation but can be subject to project-specific risks and evolving scientific needs.
Small Business Impact
The data indicates this contract was not awarded to a small business (ss: false, sb: false). There is no direct analysis of small business participation in this specific task order.
Oversight & Accountability
The task order is managed by the National Institutes of Health (NIH), a component of HHS, which has established oversight mechanisms for research grants and contracts. Accountability is tied to the delivery of research objectives.
Related Government Programs
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Lack of detailed scope for the task order.
- Potential for R&D project delays.
- Cost uncertainty inherent in research.
- No small business participation noted.
Tags
research-and-development-in-the-physical, department-of-health-and-human-services, md, delivery-order, 100m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $291.2 million to LEIDOS BIOMEDICAL RESEARCH INC. NIAID DCR OPERATIONAL TASK ORDER COVID FUNDING IN THE AMOUNT OF $3,706,224 FOR COVID RELATED EFFORTS ON THIS TASK ORDER
Who is the contractor on this award?
The obligated recipient is LEIDOS BIOMEDICAL RESEARCH INC.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $291.2 million.
What is the period of performance?
Start: 2020-08-31. End: 2024-08-30.
What specific COVID-19 research activities does this $3.7M task order fund?
The provided data does not specify the exact research activities funded by this $3.7M task order. It broadly states 'COVID related efforts.' Further details would be needed from the contract's statement of work to understand the precise nature of the research, such as vaccine development, therapeutic testing, epidemiological studies, or diagnostic research.
What are the primary risks associated with this R&D task order?
Key risks include the inherent uncertainty in research and development outcomes, potential for scope creep as research progresses, and the possibility of cost overruns if research proves more complex than anticipated. There's also a risk related to the timely delivery of research findings crucial for public health responses.
How does this funding contribute to the overall effectiveness of the NIH's COVID-19 response?
This funding contributes to the effectiveness of the NIH's COVID-19 response by supporting essential operational tasks and research efforts. By contracting with Leidos Biomedical Research Inc., the NIH can leverage specialized expertise and resources to accelerate progress in understanding and combating the virus, ultimately aiding in the development of countermeasures and public health strategies.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Pricing Type: COST PLUS FIXED FEE (U)
Evaluated Preference: NONE
Contractor Details
Parent Company: Leidos Holdings, Inc.
Address: 1050 BOYLES ST, FREDERICK, MD, 21702
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $297,601,688
Exercised Options: $297,601,688
Current Obligation: $291,244,978
Actual Outlays: $223,133,388
Subaward Activity
Number of Subawards: 21
Total Subaward Amount: $38,744,486
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Cost or Pricing Data: YES
Parent Contract
Parent Award PIID: 75N91019D00024
IDV Type: IDC
Timeline
Start Date: 2020-08-31
Current End Date: 2024-08-30
Potential End Date: 2024-08-30 00:00:00
Last Modified: 2024-06-06
More Contracts from Leidos Biomedical Research Inc
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Department of Health and Human Services)
- Federal Contract — $2.4B (Department of Health and Human Services)
- NCI Operational Task Order — $1.8B (Department of Health and Human Services)
- NCI Operational Task Order — $437.4M (Department of Health and Human Services)
- NCI FY25 Operational Task Order — $398.9M (Department of Health and Human Services)
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →